🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ab Initio developing next-gen inhaled biologicals with Prof Tuncay Alan Monash University in successful AEA grant. ab-initio-pharma.com/news/2024/9/9/…

Great to see the exciting innovations coming out of University of Sydney Sydney Solutions event on Monday night. Great opportunity to catch up with collaborators, old and new... MTPConnect #endoaxiom

Ab Initio commences work on a new joint project that may revolutionise space medicine - a multi-organ-radiation-protectant ab-initio-pharma.com/news/2024/9/13…

Discover Ab Initio's Mission: Driving Innovation in Therapeutics – An Exclusive Interview at ARCS Australia 2024 youtu.be/ZwFclAqpjz0?si…

ab-initio-pharma.com/news/2024/9/27…

ab-initio-pharma.com/news/2024/10/1…

ab-initio-pharma.com/news/2024/10/1…

Meet Lin: Leading Complex Dosage Form GMP Manufacturing at Our CDMO linkedin.com/feed/update/ur… #InnovationInAction #PharmaceuticalExcellence #CDMO

With only a week to go to AusBio2024, don't forget to book a time to meet with our team to discus all your CDMO needs #GMP #ClinicalTrials #MenInOrange ab-initio-pharma.com/news/2024/10/1…

Great to be at the Inaugural NSW Drug Discovery Forum. An exciting day of innovation ahead Anne O'Neill opens the proceedings NSW Medical Research Centre for Drug Discovery Innovation Duncan MTPConnect

Great to see all the innovation going on in the Macquarie Park Innovation District, home to Ab Initio’s R&D Centre #CDMO #innovation Macquarie University

Ab Initio Pharma was proud to support the Inaugural NSW Drug Discovery Forum and award Dr Philip Kwok the $20,000 AbVance Award for Commercialisation. ab-initio-pharma.com/news/2024/10/3…

Join Ab Initio at the Targeted Drug Delivery Innovations showcase next week, hosted by the BioNSW and BioMelbourne Network, to learn about how we are innovating in complex dosage form design and manufacture. ab-initio-pharma.com/news/2024/12/1… #BioNSW #GMP #CDMO Aptar

Ab Initio Pharma featured on BioBeacon ab-initio-pharma.com/news/2024/12/1… ARCS Australia #CDMO #GMP

Ab initios CSO, YY talks about advanced nasal drug delivery of RNA using Tetatherix matrix #ddl2024

Drop by booth 210 to learn how Ab Initio can help you develop clinic ready OINDPs at drug delivery to the lungs 2024 #GMP #formulation #DDL2024

ab-initio-pharma.com/news/2024/12/1…

Boost Your Pharma Innovation with an Aussie Advantage! At Ab Initio Pharma, we're more than just a CDMO—we're Australia's trusted partner for innovative pharmaceutical development, specialising in complex dosage forms.

Inhaled Biologics?....No problem. Read our case study here. ab-initio-pharma.com/resources/2025…

Nasal Biologics?.....No issue. Read our case study here ab-initio-pharma.com/resources/2025…